Investment Mandate:
-
Type of Transaction: Full Sale or Majority Acquisition (controlling stake).
-
Sector Focus:
-
Hospitals/Healthcare Services (e.g., specialized clinics, diagnostic labs, tertiary care facilities).
-
Generic Pharmaceuticals (e.g., manufacturing units, distribution networks).
-
Online Marketplace (e.g., B2C or B2B platforms for medical supplies, teleconsultation, or pharma retail).
-
-
Geographic Locations (Primary Focus):
-
Bhubaneswar (Odisha)
-
Vadodara (Gujarat)
-
Lucknow (Uttar Pradesh)
-
Nalagarh (Himachal Pradesh - often a key pharma manufacturing hub)
-
-
Valuation Range (Expected Enterprise Value): Rs. 1 Crore to Rs. 64 Crores (This range suggests a focus on small-to-mid-sized enterprises (SMEs) with significant growth potential).
Core Value Proposition and Context:
The businesses on offer are characterized by their "stable" operational status, implying:
-
Established Revenue Streams: Consistent financial performance and a proven business model within their respective markets.
-
Operational Maturity: Existing infrastructure, established vendor/supplier relationships, and a competent management/staff framework.
Resilience: Operations in sectors (healthcare and pharma) that are inherently non-cyclical and robust, ensuring long-term stability and demand.